Cor Vasa 2007, 49(3):111-114 | DOI: 10.33678/cor.2007.041

Příspěvek k článku Jiřího Spáčila a Jana Petráška: Kardiostimulace v některých pražských nemocnicích v posledních letech, který byl otištěn v Cor et Vasa 2007;49(1):35-36. Výběr stimulačního režimu u nemocných indikovaných k implantaci kardiostimulátoru

Vlastimil Vančura
Klinika kardiologie, Institut klinické a experimentální medicíny

Published: March 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vančura V. Příspěvek k článku Jiřího Spáčila a Jana Petráška: Kardiostimulace v některých pražských nemocnicích v posledních letech, který byl otištěn v Cor et Vasa 2007;49(1):35-36. Výběr stimulačního režimu u nemocných indikovaných k implantaci kardiostimulátoru. Cor Vasa. 2007;49(3):111-114. doi: 10.33678/cor.2007.041.
Download citation

References

  1. Spáčil J, Petrášek J. Kardiostimulace v některých pražských nemocnicích v posledních letech. Cor Vasa 2007; 49:35-6. Go to original source...
  2. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344(8936):1523-8. Go to original source... Go to PubMed...
  3. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350(9086):1210-6. Go to original source... Go to PubMed...
  4. Lamas GA, Orav EJ, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. New Engl J Med 1998;338:1097-104. Go to original source... Go to PubMed...
  5. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. New Engl J Med 2000;342:1385-91. Go to original source... Go to PubMed...
  6. Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. New Engl J Med 2002;346:1854-62. Go to original source... Go to PubMed...
  7. Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. New Engl J Med 2005;353:145-55. Go to original source... Go to PubMed...
  8. Stambler BS, Ellenbogen KA, Orav EJ, et al. Predictors and clinical impact of atrial fibrillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing. Pac Clin Electrophysiol 2003;26:2000-7. Go to original source... Go to PubMed...
  9. Skanes AC, Krahn AD, Yee R, et al. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. J Am Coll Cardiol 2001;38:167-72. Go to original source... Go to PubMed...
  10. Kerr CR, Connolly SJ, Abdollah H, et al. Canadian Trial of Physiological Pacing: Effects of physiological pacing during long-term follow-up. Circulation 2004;109:357-62. Go to original source... Go to PubMed...
  11. Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol 2003;42:614-23. Go to original source... Go to PubMed...
  12. Tang AS, Roberts RS, Kerr C, at al. Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes. Circulation 2001; 103:3081-5. Go to original source... Go to PubMed...
  13. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-7. Go to original source... Go to PubMed...
  14. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288:3115-23. Go to original source... Go to PubMed...
  15. Sharma AD, Rizo-Patron C, Hallstrom AP, et al. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005;2:830-4. Go to original source... Go to PubMed...
  16. Tops LF, Schalij MJ, Holman ER, van Erven L, van der Wall EE, Bax JJ. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 2006;48:1642-8. Go to original source... Go to PubMed...
  17. Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardio Electrophysiol 2005;16:1160-5. Go to original source... Go to PubMed...
  18. Hayes JJ, Sharma AD, Love JC, Herre JM, Leonen AO, Kudenchuk PJ. Abnormal conduction increases risk of adverse outcomes from right ventricular pacing. J Am Coll Cardiol 2006;48:1628-33. Go to original source... Go to PubMed...
  19. Vollmann D, Luthje L, Schott P, Hasenfuss G, Unterberg-Buchwald C. Biventricular pacing improves the blunted force-frequency relation present during univentricular pacing in patients with heart failure and conduction delay. Circulation 2006;113:953-9. Go to original source... Go to PubMed...
  20. Gillis AM, Purerfellner H, Israel CW, et al. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Pacing Clin Electrophysiol 2006; 29:697-705. Go to original source... Go to PubMed...
  21. Táborský M, Kautzner J, Bytešník J, a spol. Zásady pro implantace kardiostimulátorů, implantabilních kardioverterů-defibrilátorů a srdeční resynchronizační léčbu (2005). Cor Vasa 2005;47:59-68.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.